J&J hands Congress 20K pages of Tylenol documentation

J&J continues to hand over to Congress some 20,000 pages of documentation concerning the Tylenol and other children's medication recalls that originated at its GMP-violation-riddled Pennsylvania plant. The page count exceeds 20,000, with more to come. The documents are stacked in the House Oversight and Government Reform Committee in-box, on top of more than 1,000 pages collected from the of FDA. Report

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.